Chromatography assets from Novasep

Sartorius, through its French listed subgroup Sartorius Stedim Biotech, acquired the Novasep chromatography division in 2022. The unit comprises resin-based batch and intensified chromatography systems, and primarily focuses on high-pressure, multi-use applications for smaller molecules, such as oligonucleotides, peptides and insulin.